EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 Patients

Bogdan Cylwik, Kacper Gan, Marcin Kazberuk iD, Ewa Gruszewska iD, Anatol Panasiuk, Magdalena Sienkiewicz, Malgorzata Wojtkowska, Lech Chrostek iD

International Journal of Molecular Sciences · 08.05.2026 · 27 (10) · 4190

DOI: 10.3390/ijms27104190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.05.2026. Verfasst von Bogdan Cylwik und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Laboratory Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland. Hauptthemen laut MEDLINE: Chemokine CCL2, COVID-19, Interleukin-18, Pulmonary Fibrosis. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study evaluated the diagnostic usefulness of surfactant protein D (SP-D), chemokine C-C motif ligand 2/monocyte chemoattractant protein-1 (CCL2/MCP-1), and interleukin 18 (IL-18) in patients with SARS-CoV-2 infection. The authors focused on lung failure assessment, lung parenchyma involvement, and the early assessment of the risk of developing pulmonary fibrosis at the onset of COVID-19. The study group included 87 patients with COVID-19 and 45 healthy subjects. Concentrations of all three markers were measured using the enzyme immunoassay method. The serum SP-D, CCL2/MCP-1, and IL-18 concentrations were significantly higher in the COVID-19 patients before admission to the hospital than those in the controls (p < 0.001 for all comparisons). Differences were only found in the IL-18 levels between the groups categorized according to disease severity (p < 0.001); levels were significantly higher in patients with critical disease severity compared to those with moderate disease severity (p < 0.001). IL-18 also showed a positive correlation with the disease severity (p = 0.025). SP-D and IL-18 levels varied depending on the amount of oxygen administration (p = 0.017 and p < 0.001, respectively). Among the blood gas parameters, SP-D levels were negatively associated with the partial pressure of arterial oxygen (PaO2) and oxygen saturation (O2Sat) (p = 0.026 and p = 0.048, respectively), IL-18 with O2Sat (p = 0.036), and CCL2/MCP-1 with PaO2 (p = 0.042). SP-D and IL-18 were significantly negatively correlated with oxygen therapy (p = 0.003 and p = 0.014, respectively). Conversely, CCL2/MCP-1 was significantly positively correlated with the pulmonary involvement severity (p = 0.017) and level of hyaluronic acid (HA), a marker of fibrosis (p = 0.042). We also observed a significant correlation between the IL-18 level and the pulmonary involvement severity (p < 0.001), HA (p < 0.001), and other markers of fibrosis. In summary, our study’s results indicate that SP-D, CCL2/MCP-1, and IL-18 may be used to assess lung function in the early stage of COVID-19 infection; additionally, SP-D may serve as an indicator of alveolar injury, while CCL2/MCP-1 and IL-18 may be markers of lung parenchyma involvement and potential predictors of the development of pulmonary fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemokine CCL2COVID-19Interleukin-18Pulmonary FibrosisPulmonary Surfactant-Associated Protein DAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultBiomarkersRespirationRespiratory InsufficiencyThoraxTomography, X-Ray Computed

Stichwörter der Autor:innen

CCL2/MCP-1 IL-18COVID-19 patientsSP-D

Substanzen

BiomarkersCCL2 protein, humanChemokine CCL2IL18 protein, humanInterleukin-18Pulmonary Surfactant-Associated Protein D

Autor:innen und Institutionen

  • Department of Paediatric Laboratory Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
  • Department of Gastroenterology, Hepatology and Internal Diseases, Voivodeship Hospital in Bialystok, 15-278 Bialystok, Poland.
  • Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
  • Department of Clinical Medicine, Medical University of Bialystok, 15-269 Bialystok, Poland.
  • Department of Paediatric Laboratory Diagnostics, Medical University of Bialystok Children's Clinical Hospital, 15-274 Bialystok, Poland.

ORCID-Profile: Marcin Kazberuk, Ewa Gruszewska, Lech Chrostek

Zitieren

APA

Cylwik, B., Gan, K., Kazberuk, M., Gruszewska, E., Panasiuk, A., Sienkiewicz, M., Wojtkowska, M., & Chrostek, L. (2026). Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 Patients. International Journal of Molecular Sciences, 27(10), 4190. https://doi.org/10.3390/ijms27104190

Vancouver

Cylwik B, Gan K, Kazberuk M, Gruszewska E, Panasiuk A, Sienkiewicz M, et al. Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 Patients. International Journal of Molecular Sciences. 2026;27(10):4190. doi:10.3390/ijms27104190

BibTeX
@article{Cylwik2026,
  author = {Cylwik, Bogdan and Gan, Kacper and Kazberuk, Marcin and Gruszewska, Ewa and Panasiuk, Anatol and Sienkiewicz, Magdalena and Wojtkowska, Malgorzata and Chrostek, Lech},
  title = {Diagnostic Usefulness of SP-D, CCL2/MCP-1, and IL-18 in Assessing Respiratory Function and Risk of Pulmonary Fibrosis in COVID-19 Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {10},
  pages = {4190},
  doi = {10.3390/ijms27104190}
}
Kostenlos starten →